Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $11,575 | 5 | 63.3% |
| Food and Beverage | $4,902 | 148 | 26.8% |
| Travel and Lodging | $1,806 | 8 | 9.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Neurocrine Biosciences, Inc. | $5,685 | 24 | $0 (2024) |
| Lilly USA, LLC | $4,466 | 25 | $0 (2022) |
| Eli Lilly and Company | $4,425 | 2 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $1,361 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $674.78 | 23 | $0 (2024) |
| PFIZER INC. | $327.15 | 20 | $0 (2020) |
| ACADIA Pharmaceuticals Inc | $269.62 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $263.73 | 9 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $139.94 | 2 | $0 (2023) |
| Sunovion Pharmaceuticals Inc. | $131.32 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,123 | 14 | Eli Lilly and Company ($4,425) |
| 2023 | $5,710 | 22 | Neurocrine Biosciences, Inc. ($5,351) |
| 2022 | $5,072 | 25 | Lilly USA, LLC ($4,323) |
| 2021 | $458.74 | 14 | ACADIA Pharmaceuticals Inc ($145.39) |
| 2020 | $185.60 | 5 | Sun Pharmaceutical Industries Inc. ($103.11) |
| 2019 | $1,174 | 48 | Sun Pharmaceutical Industries Inc. ($463.99) |
| 2018 | $524.15 | 31 | AstraZeneca Pharmaceuticals LP ($123.09) |
| 2017 | $36.56 | 2 | Janssen Pharmaceuticals, Inc ($19.75) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/20/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $139.83 | General |
| 10/19/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $23.09 | General |
| 08/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $4.45 | General |
| Category: Neuropsychiatry | ||||||
| 08/16/2024 | Eli Lilly and Company | KISUNLA (Drug) | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| Category: Neuroscience | ||||||
| 08/16/2024 | Eli Lilly and Company | KISUNLA (Drug) | Consulting Fee | Cash or cash equivalent | $1,050.00 | General |
| Category: Neuroscience | ||||||
| 07/24/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $7.83 | General |
| Category: Neuropsychiatry | ||||||
| 06/13/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: Neuropsychiatry | ||||||
| 05/10/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.94 | General |
| Category: Neuropsychiatry | ||||||
| 04/26/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $124.23 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 04/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $107.88 | General |
| 04/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $10.58 | General |
| Category: Neuropsychiatry | ||||||
| 03/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | — | Food and Beverage | In-kind items and services | $98.82 | General |
| 02/23/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $27.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $121.36 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/03/2023 | Neurocrine Biosciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 10/25/2023 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | Cash or cash equivalent | $223.88 | General |
| 10/25/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $66.42 | General |
| 10/25/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $39.40 | General |
| 10/25/2023 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | In-kind items and services | $28.00 | General |
| 10/25/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $19.17 | General |
| 10/25/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $4.05 | General |
| 10/24/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $106.50 | General |
| 10/24/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $11.29 | General |
| 10/19/2023 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $76.23 | General |
| 10/17/2023 | Neurocrine Biosciences, Inc. | — | Travel and Lodging | Cash or cash equivalent | $756.96 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 273 | 412 | $105,104 | $37,815 |
| 2022 | 2 | 370 | 540 | $117,356 | $41,021 |
| 2021 | 4 | 307 | 457 | $76,651 | $30,057 |
| 2020 | 16 | 860 | 1,061 | $140,134 | $60,372 |
All Medicare Procedures & Services
26 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 151 | 202 | $72,451 | $25,987 | 35.9% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 75 | 148 | $22,073 | $8,127 | 36.8% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 32 | 44 | $8,938 | $3,464 | 38.8% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 15 | 18 | $1,642 | $236.08 | 14.4% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 228 | 274 | $93,439 | $32,749 | 35.0% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 142 | 266 | $23,916 | $8,272 | 34.6% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 136 | 157 | $48,559 | $20,091 | 41.4% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 99 | 219 | $17,866 | $7,347 | 41.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 61 | 69 | $8,694 | $1,987 | 22.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 11 | 12 | $1,532 | $632.64 | 41.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 174 | 174 | $35,144 | $19,443 | 55.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 232 | 341 | $42,966 | $16,914 | 39.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 112 | 135 | $25,515 | $7,354 | 28.8% |
| 90682 | Vaccine for influenza for injection into muscle | Office | 2020 | 56 | 57 | $3,306 | $3,303 | 99.9% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2020 | 15 | 15 | $4,950 | $2,465 | 49.8% |
| 99490 | Chronic care management services at least 20 minutes per calendar month | Office | 2020 | 17 | 73 | $5,402 | $2,286 | 42.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 20 | 20 | $3,800 | $1,453 | 38.2% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 48 | 51 | $3,825 | $1,390 | 36.3% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 17 | 19 | $2,775 | $1,377 | 49.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 26 | 27 | $2,665 | $1,259 | 47.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 57 | 58 | $2,378 | $920.14 | 38.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $3,135 | $893.89 | 28.5% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 17 | 19 | $2,090 | $653.98 | 31.3% |
| 82274 | Stool analysis for blood | Office | 2020 | 19 | 19 | $627.00 | $302.16 | 48.2% |
| 69209 | Removal of impacted ear wax by washing | Office | 2020 | 26 | 27 | $896.00 | $237.15 | 26.5% |
About Dr. Robert Russell, MD
Dr. Robert Russell, MD is a Internal Medicine healthcare provider based in Lafayette, Indiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2007. The National Provider Identifier (NPI) number assigned to this provider is 1407052376.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Russell, MD has received a total of $18,283 in payments from pharmaceutical and medical device companies, with $5,123 received in 2024. These payments were reported across 161 transactions from 23 companies. The most common payment nature is "Consulting Fee" ($11,575).
As a Medicare-enrolled provider, Russell has provided services to 1,810 Medicare beneficiaries, totaling 2,470 services with total Medicare billing of $169,265. Data is available for 4 years (2020–2023), covering 26 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lafayette, IN
- Active Since 06/26/2007
- Last Updated 01/24/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1407052376
Products in Payments
- KISUNLA (Drug) $4,425
- LOKELMA (Drug) $370.98
- NUPLAZID (Drug) $269.62
- XARELTO (Drug) $252.86
- EZALLOR SPRINKLE (Drug) $233.53
- INGREZZA (Drug) $212.87
- ELIQUIS (Drug) $210.57
- SYMBICORT (Drug) $192.24
- KAPSPARGO (Drug) $141.09
- ABILIFY ASIMTUFII (Drug) $139.94
- APTIOM (Drug) $135.01
- TRULICITY (Drug) $131.13
- MYRBETRIQ (Drug) $123.76
- DRIZALMA SPRINKLE (Drug) $121.55
- CHANTIX (Drug) $116.58
- FARXIGA (Drug) $99.47
- RIOMET (Drug) $97.32
- Proclaim IPG (Device) $63.06
- Nuedexta (Drug) $42.66
- Ozempic (Drug) $38.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lafayette
Steven Steinhubl, Md, MD
Internal Medicine — Payments: $172,128
Dr. Eric Trawick, Md, MD
Internal Medicine — Payments: $83,507
Dr. Brent Rochon, Md, MD
Internal Medicine — Payments: $23,953
Hector Robles, Md, MD
Internal Medicine — Payments: $23,742
Nethuja Salagundla, M.d, M.D
Internal Medicine — Payments: $17,501
Dr. Maha Toma, M.d, M.D
Internal Medicine — Payments: $17,223